Scientific Research News

SAN CARLOS, Calif.--(BUSINESS WIRE)--Cerepeut, Inc., a biotechnology company developing mitochondrial therapeutics for neurodegenerative disease, today announced publication of a landmark study in Neuron revealing why the brain turns on itself in Alzheimer's disease and related disorders, and unveiling a drug candidate designed to stop it. Tau is a well-known driver of Alzheimer's, notorious for clumping into toxic tangles inside dying neurons. What scientists didn't know was that tau also moon...

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle recently welcomed members of the National Security Commission on Emerging Biotechnology (NSCEB) to its Columbus headquarters as part of the NSCEB’s national roadshow providing an inside look at biotechnology research, biosecurity capabilities and partnerships advancing U.S. competitiveness, supply chain resilience and national security. The visit brought together Commission members, congressional staff, biotechnology leaders, government partners, academ...

--(BUSINESS WIRE)--General Atomics: WHAT: San Diego will once again have a rare opportunity to step inside one of the nation’s leading fusion research facilities. After drawing strong public interest in the spring, General Atomics is reopening the DIII-D National Fusion Facility for public tours this October in celebration of Nuclear Science Week. DIII-D (pronounced “Dee-three-dee”) is a U.S. Department of Energy Office of Science user facility operated by General Atomics and the largest operat...

DALLAS--(BUSINESS WIRE)--The Colossal Foundation, the 501(c)(3) charitable organization of Colossal Biosciences, has announced the second cohort of its Species Reintroduction Fund, expanding the program to seven new species across four continents. In collaboration with the global conservation nonprofit Re:wild, the Fund will direct its annual commitment of $250,000 to teams working in Cambodia, the United States, Brazil, Guatemala, Australia, and Canada. Launched in 2025 as the first fund in th...

AUSTIN, Texas--(BUSINESS WIRE)--Equine Performance Labs (EPL), the team behind equicenta® CTM — announced the publication of a peer-reviewed, prospective, controlled clinical trial demonstrating that a single, ready-to-use injection of equicenta® CTM produced significantly better clinical outcomes than clinician-selected standard of care (SOC) in lame performance horses. The study was accepted June 29, 2026 in Frontiers in Veterinary Science (Veterinary Regenerative Medicine section) and repres...

LAS VEGAS--(BUSINESS WIRE)--Massive Bio, a global precision oncology company, today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI fronti...

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Space Microgravity Development LLC (SpaceMD), a wholly owned subsidiary of Redwire Corporation (NYSE:RDW) and venture company focused on leveraging the microgravity environment to create dynamic innovations, announced today that it has signed a contract for a Starfall mission. Starfall is SpaceX’s new spacecraft that enables affordable, routine access to a microgravity environment and provides unique opportunities for on-orbit manufacturing, scientific resea...

TULSA, Okla.--(BUSINESS WIRE)--Four startups headquartered in Colorado, Florida and Texas have been selected as winners of the 2026 Rose Rock Bridge Showcase. Austere Environmental, BiaTech, BigMachine AI and Intellicess will receive a share of $400,000 in non-dilutive funding and establish a presence in Tulsa to pilot and advance their technologies over the next year. The winning startups were selected from a pool of 85 highly qualified applicants. Collectively, they have already raised over $...

ST. LOUIS--(BUSINESS WIRE)--Belden Inc. (NYSE: BDC), a leading global provider of complete connection solutions is pleased to announce that it has been recognized as a World’s Top Disability Inclusive Business based on its performance on the Disability Index®, the leading global benchmark for disability inclusion in business. Belden earned the Established level of proficiency which reflects the company's ongoing commitment to creating a workplace where everyone can thrive, with strong performan...

LOS ANGELES--(BUSINESS WIRE)--Experts at City of Hope®, one of the nation’s largest and most advanced cancer research and treatment organizations, are shining a spotlight on the risk of skin cancer faced by hematopoietic cell transplant (HCT) survivors, as well as the need for early detection. New City of Hope research published in JNCCN—Journal of the National Comprehensive Cancer Network shows how a cost-effective, scalable education program targeting survivors and their doctors can significa...